Carnitine-associated encephalopathy caused by long-term treatment with an antibiotic containing pivalic acid.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 17724113.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An 18-month-old boy was treated with an antibiotic containing pivalic acid for 6 months for intractable otitis media and then developed repeated convulsions and loss of consciousness. Laboratory data showed hypoglycemia and hypocarnitinemia. Intravenous administration of glucose was ineffective against the seizures and loss of consciousness. However, the patient regained consciousness and recovered soon after intravenous infusion of carnitine. To our knowledge, intravenous carnitine administration that contributed to marked improvements in neurologic deficit caused by administration of an antibiotic containing pivalic acid has not been reported previously. These findings indicate that long-term use of such antibiotics should be avoided.
Medical subject headings
- Anti-Bacterial Agents
- Brain Diseases, Metabolic
- Carnitine
- Cephalosporins
- Pentanoic Acids